Kamuvudine-9
N/A
Report date: 2026/04/07 20:00:20
NME
Base Information
Drug NameKamuvudine-9
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInflammasome Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesVistar Eye Center
Inactive CompaniesInflammasome Therapeutics Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A